OTCMKTS:CLVLY

Clinuvel Pharmaceuticals Competitors

$22.51
-0.06 (-0.24 %)
(As of 04/13/2021 02:47 PM ET)
Add
Compare
Today's Range
$22.51
Now: $22.51
$22.51
50-Day Range
$15.91
MA: $19.96
$22.86
52-Week Range
$12.56
Now: $22.51
$22.90
Volume210 shs
Average Volume7,290 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Clinuvel Pharmaceuticals (OTCMKTS:CLVLY) Vs. DDXS, TNGN, ATTBF, ACHL, ADTX, and AGNPF

Should you be buying CLVLY stock or one of its competitors? Companies in the industry of "biotechnology" are considered alternatives and competitors to Clinuvel Pharmaceuticals, including (DDXS) (DDXS), (TNGN) (TNGN), Abattis Bioceuticals (ATTBF), Achilles Therapeutics plc American Depositary Shares (ACHL), ADiTx Therapeutics (ADTX), and Algernon Pharmaceuticals (AGNPF).

(DDXS) (OTCMKTS:DDXS) and Clinuvel Pharmaceuticals (OTCMKTS:CLVLY) are both health technology companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, valuation, earnings, risk and analyst recommendations.

Profitability

This table compares (DDXS) and Clinuvel Pharmaceuticals' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
(DDXS)N/AN/AN/A
Clinuvel PharmaceuticalsN/AN/AN/A

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for (DDXS) and Clinuvel Pharmaceuticals, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
(DDXS)0000N/A
Clinuvel Pharmaceuticals00103.00

Valuation & Earnings

This table compares (DDXS) and Clinuvel Pharmaceuticals' revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
(DDXS)N/AN/AN/AN/AN/A
Clinuvel PharmaceuticalsN/AN/AN/AN/AN/A

Summary

Clinuvel Pharmaceuticals beats (DDXS) on 1 of the 1 factors compared between the two stocks.

(TNGN) (OTCMKTS:TNGN) and Clinuvel Pharmaceuticals (OTCMKTS:CLVLY) are both health technology companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, valuation, earnings, risk and analyst recommendations.

Profitability

This table compares (TNGN) and Clinuvel Pharmaceuticals' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
(TNGN)N/AN/AN/A
Clinuvel PharmaceuticalsN/AN/AN/A

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for (TNGN) and Clinuvel Pharmaceuticals, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
(TNGN)0000N/A
Clinuvel Pharmaceuticals00103.00

Valuation & Earnings

This table compares (TNGN) and Clinuvel Pharmaceuticals' revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
(TNGN)N/AN/AN/AN/AN/A
Clinuvel PharmaceuticalsN/AN/AN/AN/AN/A

Summary

Clinuvel Pharmaceuticals beats (TNGN) on 1 of the 1 factors compared between the two stocks.

Abattis Bioceuticals (OTCMKTS:ATTBF) and Clinuvel Pharmaceuticals (OTCMKTS:CLVLY) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, valuation, earnings, risk and analyst recommendations.

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for Abattis Bioceuticals and Clinuvel Pharmaceuticals, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Abattis Bioceuticals0000N/A
Clinuvel Pharmaceuticals00103.00

Profitability

This table compares Abattis Bioceuticals and Clinuvel Pharmaceuticals' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Abattis BioceuticalsN/AN/AN/A
Clinuvel PharmaceuticalsN/AN/AN/A

Valuation & Earnings

This table compares Abattis Bioceuticals and Clinuvel Pharmaceuticals' revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Abattis BioceuticalsN/AN/AN/AN/AN/A
Clinuvel PharmaceuticalsN/AN/AN/AN/AN/A

Summary

Clinuvel Pharmaceuticals beats Abattis Bioceuticals on 1 of the 1 factors compared between the two stocks.

Clinuvel Pharmaceuticals (OTCMKTS:CLVLY) and Achilles Therapeutics plc American Depositary Shares (NASDAQ:ACHL) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, dividends, valuation, institutional ownership, profitability and risk.

Analyst Ratings

This is a summary of current ratings for Clinuvel Pharmaceuticals and Achilles Therapeutics plc American Depositary Shares, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Clinuvel Pharmaceuticals00103.00
Achilles Therapeutics plc American Depositary Shares0000N/A

Profitability

This table compares Clinuvel Pharmaceuticals and Achilles Therapeutics plc American Depositary Shares' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Clinuvel PharmaceuticalsN/AN/AN/A
Achilles Therapeutics plc American Depositary SharesN/AN/AN/A

Valuation and Earnings

This table compares Clinuvel Pharmaceuticals and Achilles Therapeutics plc American Depositary Shares' revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Clinuvel PharmaceuticalsN/AN/AN/AN/AN/A
Achilles Therapeutics plc American Depositary SharesN/AN/AN/AN/AN/A

Summary

Clinuvel Pharmaceuticals beats Achilles Therapeutics plc American Depositary Shares on 1 of the 1 factors compared between the two stocks.

Clinuvel Pharmaceuticals (OTCMKTS:CLVLY) and ADiTx Therapeutics (NASDAQ:ADTX) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, dividends, valuation, institutional ownership, profitability and risk.

Analyst Ratings

This is a summary of current ratings for Clinuvel Pharmaceuticals and ADiTx Therapeutics, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Clinuvel Pharmaceuticals00103.00
ADiTx Therapeutics00103.00

Profitability

This table compares Clinuvel Pharmaceuticals and ADiTx Therapeutics' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Clinuvel PharmaceuticalsN/AN/AN/A
ADiTx TherapeuticsN/AN/AN/A

Valuation and Earnings

This table compares Clinuvel Pharmaceuticals and ADiTx Therapeutics' revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Clinuvel PharmaceuticalsN/AN/AN/AN/AN/A
ADiTx TherapeuticsN/AN/AN/AN/AN/A

Clinuvel Pharmaceuticals (OTCMKTS:CLVLY) and Algernon Pharmaceuticals (OTCMKTS:AGNPF) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, dividends, valuation, institutional ownership, profitability and risk.

Analyst Ratings

This is a summary of current ratings for Clinuvel Pharmaceuticals and Algernon Pharmaceuticals, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Clinuvel Pharmaceuticals00103.00
Algernon Pharmaceuticals0000N/A

Profitability

This table compares Clinuvel Pharmaceuticals and Algernon Pharmaceuticals' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Clinuvel PharmaceuticalsN/AN/AN/A
Algernon PharmaceuticalsN/AN/AN/A

Valuation and Earnings

This table compares Clinuvel Pharmaceuticals and Algernon Pharmaceuticals' revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Clinuvel PharmaceuticalsN/AN/AN/AN/AN/A
Algernon PharmaceuticalsN/AN/AN/AN/AN/A

Summary

Clinuvel Pharmaceuticals beats Algernon Pharmaceuticals on 1 of the 1 factors compared between the two stocks.


Clinuvel Pharmaceuticals Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
(DDXS) logo
DDXS
(DDXS)
0.5$0.00-0.0%$0.00N/A0.00
TNGN
(TNGN)
0.4N/AN/A$0.00N/A0.00Gap Up
Abattis Bioceuticals logo
ATTBF
Abattis Bioceuticals
0.4$0.02-0.0%$0.00N/A0.00
ACHL
Achilles Therapeutics plc American Depositary Shares
0.0$13.73-5.5%$0.00N/A0.00Gap Down
ADiTx Therapeutics logo
ADTX
ADiTx Therapeutics
1.0$2.81-2.8%$0.00N/A0.00News Coverage
Algernon Pharmaceuticals logo
AGNPF
Algernon Pharmaceuticals
0.0$0.14-7.2%$0.00N/A0.00Increase in Short Interest
Almirall logo
LBTSF
Almirall
0.5$15.00-0.0%$0.00N/A0.00
Apotheca Biosciences logo
CBDC
Apotheca Biosciences
0.4$0.08-0.0%$0.00N/A0.00
ARNI
Arno Therapeutics
0.5$0.01-0.0%$0.00N/A0.00
ASCLF
Ascletis Pharma
0.4$0.37-0.0%$0.00N/A0.00News Coverage
Avid Bioservices logo
CDMOP
Avid Bioservices
0.3$25.06-0.0%$0.00N/A0.00Increase in Short Interest
News Coverage
AXIM Biotechnologies logo
AXIM
AXIM Biotechnologies
0.4$0.62-4.8%$0.00N/A0.00Gap Up
BXRXV
Baudax Bio
0.5N/AN/A$0.00N/A0.00High Trading Volume
BerGenBio ASA logo
BRRGF
BerGenBio ASA
0.7$3.52-0.0%$0.00N/A0.00
Cannabics Pharmaceuticals logo
CNBX
Cannabics Pharmaceuticals
0.4$0.22-13.4%$0.00N/A0.00High Trading Volume
Increase in Short Interest
News Coverage
ORHOF
CannaRoyalty
0.7$9.23-56.1%$0.00N/A0.00Gap Down
Cerebain Biotech logo
CBBT
Cerebain Biotech
0.0$0.04-0.0%$0.00N/A0.00Increase in Short Interest
Gap Up
CGYG
China Longyi Group International
0.4$0.00-0.0%$0.00N/A0.00
CELZ
Creative Medical Technology
0.5$0.05-0.0%$0.00N/A0.00Gap Up
Cybin logo
CLXPF
Cybin
1.0$1.48-3.4%$0.00N/A0.00News Coverage
Eastgate Biotech logo
ETBI
Eastgate Biotech
0.5$0.00-28.6%$0.00N/A0.00Gap Down
EMMBF
Emblem
0.6$1.40-1.4%$0.00N/A0.00
ENZC
Enzolytics
0.0$0.22-8.9%$0.00N/A0.00
GB Sciences logo
GBLX
GB Sciences
0.5$0.05-0.0%$0.00N/A0.00Increase in Short Interest
Gap Down
Genfit logo
GNFTF
Genfit
0.5$4.63-0.4%$0.00N/A0.00Decrease in Short Interest
Gap Up
GMXAY
GENMAB A/S/S
0.5$34.65-3.1%$0.00N/A0.00High Trading Volume
Gap Down
Genus logo
GENSF
Genus
0.7$69.40-0.0%$0.00N/A0.00Decrease in Short Interest
News Coverage
HALB
Halberd
0.0$0.04-0.0%$0.00N/A0.00Gap Down
HAVN Life Sciences logo
HAVLF
HAVN Life Sciences
0.0$0.58-5.2%$0.00N/A0.00Decrease in Short Interest
Gap Up
Idorsia logo
IDRSF
Idorsia
0.5$27.18-0.0%$0.00N/A0.00
IPATF
ImmunoPrecise Antibodies
0.5N/AN/A$0.00N/A0.00High Trading Volume
IMLFF
InMed Pharmaceuticals
0.6N/AN/A$0.00N/A0.00High Trading Volume
Innovation Pharmaceuticals logo
IPIX
Innovation Pharmaceuticals
0.6$0.27-3.7%$0.00N/A0.00News Coverage
Kalytera Therapeutics logo
KALTF
Kalytera Therapeutics
0.6$0.04-0.0%$0.00N/A0.00Increase in Short Interest
Gap Down
Medican Enterprises logo
MDCN
Medican Enterprises
0.5$0.00-0.0%$0.00N/A0.00Decrease in Short Interest
Mesoblast logo
MEOBF
Mesoblast
0.5$1.72-2.9%$0.00N/A0.00Gap Down
MCURF
Mind Cure Health
0.0$0.35-0.0%$0.00N/A0.00Increase in Short Interest
Mind Medicine (MindMed) logo
MMEDF
Mind Medicine (MindMed)
1.1$2.52-3.2%$0.00N/A0.00
Molecular Partners logo
MLLCF
Molecular Partners
0.5$25.25-1.0%$0.00N/A0.00Gap Down
MPSYF
MorphoSys
0.0$88.15-0.0%$0.00N/A0.00
NRNVF
Nordic Nanovector ASA
0.0$1.64-0.0%$0.00N/A0.00High Trading Volume
Novozymes A/S logo
NVZMF
Novozymes A/S
0.4$65.23-1.3%$0.00N/A0.00
BPSR
Organicell Regenerative Medicine
0.5$0.06-0.0%$0.00N/A0.00Increase in Short Interest
News Coverage
Oxurion logo
TBGNF
Oxurion
0.5$2.75-0.0%$0.00N/A0.00
Pharnext logo
PNEXF
Pharnext
0.0$4.11-0.0%$0.00N/A0.00Decrease in Short Interest
News Coverage
PTEO
Proteo
0.5$0.09-0.0%$0.00N/A0.00
PROT
Proteonomix
0.5$0.01-0.0%$0.00N/A0.00Increase in Short Interest
News Coverage
ProtoKinetix logo
PKTX
ProtoKinetix
0.5$0.26-3.8%$0.00N/A0.00Decrease in Short Interest
News Coverage
PureTech Health logo
PTCHF
PureTech Health
0.0$5.74-1.0%$0.00N/A0.00Decrease in Short Interest
RCPHF
Recipharm AB (publ)
1.0$16.05-0.0%$0.00N/A0.00High Trading Volume
This page was last updated on 4/14/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.